On February 8, 2023, Liaoning Kangbaier Biotechnology Development Co., Ltd. held the “Cangbaier US OTC Listing Celebration” in the Sofitel Ballroom of Panjin Ligang International Hotel. Relevant government leaders, listing service team, strategic cooperation units, managers of franchised chain stores, and more than 500 shareholders and employees of the company gathered together to share the joy of Kangbaier entering the international capital market.
Liaoning Kangbaier Biotechnology Development Co., Ltd., affiliated to Panjin Shuangying Group, uses the carrot cell wall breaking technology of the Chinese Academy of Sciences and the high-temperature non-enzyme technology of Germany to focus on natural
At the beginning of 2020, Kangbaier signed the “Listing and Listing Service Agreement” with the United Business Association of the United States and the Overseas Listed Capital Group of Small and Medium-sized Enterprises; signed the “Legal Service Agreement” with Beijing Jingtian & Gongcheng Law Firm, a well-known Asian law firm; to sign
Disclaimer: The above content is transferred from other media by this website. The relevant information is only for the purpose of conveying more information. It does not represent the views of this website, nor does it mean that this website agrees with its views or confirms the authenticity of its content. If you have any questions or doubts about this manuscript, please contact us at [email protected], and we will reply you as soon as possible.